Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07561268 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Stenting Of Symptomatic Cerebral siNus stenosIs With the laserCut Self-expanding SILANCE Stent

Study acronym: SONIC
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The objective of this clinical investigation is to evaluate and demonstrate the clinical benefit, performance, and safety of the SILANCE Stent, which is specifically designed for the treatment of patients with symptomatic sinus stenoses associated with IIH.
Trial Details
NCT Number NCT07561268
Lead Sponsor Acandis GmbH
Conditions
(from sponsor)		 Idiopathic Intracranial Hypertension (IIH)
Related terms Pseudotumor Cerebri
Enrollment 99 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov